eMedicine Specialties > Emergency Medicine > Neurology

Myasthenia Gravis: Differential Diagnoses & Workup

Author: William D Goldenberg, MD, Clinical Assistant Instructor, Department of Emergency Medicine, Kings County Hospital Center and SUNY Downstate Medical Center
Coauthor(s): Richard H Sinert, DO, Associate Professor of Emergency Medicine, Clinical Assistant Professor of Medicine, Research Director, State University of New York College of Medicine; Consulting Staff, Department of Emergency Medicine, Kings County Hospital Center
Contributor Information and Disclosures

Updated: Jan 30, 2009

Differential Diagnoses

Myocardial Infarction
Pulmonary Embolism

Workup

Laboratory Studies

  • No laboratory tests are available in a time frame that is useful to confirm the emergency diagnosis of myasthenia gravis (MG).
  • An arterial blood gas determination can help guide respiratory management and should be obtained early. An elevated pCO2 suggests progressive respiratory failure and may indicate the need for emergency airway management.

Imaging Studies

  • Chest radiography is indicated to determine the presence of aspiration or other pneumonias, which commonly occur in patients with myasthenia gravis.
  • CT scan or MRI of the chest is highly accurate in detecting thymoma. Every patient with myasthenia gravis should be screened for thymoma. Chest radiography is relatively insensitive in screening for thymoma, as it does not detect up to 30% of cases.

Other Tests

  • Tensilon (edrophonium) challenge test is useful in diagnosing myasthenia gravis and in distinguishing myasthenic crisis from cholinergic crisis due to its rapid onset and short duration of action.5,6 A positive response is not completely specific for myasthenia gravis because several other conditions (eg, amyotrophic lateral sclerosis) may also respond to edrophonium with increased strength. Once the patient's airway and ventilation are secured, an initial test dose of edrophonium is given. Some patients may respond noticeably to a small dose (1 mg). If no adverse reaction occurs following the test dose, another dose (3 mg) of edrophonium should produce noticeable improvement in muscle strength within 1 minute.6 If no improvement occurs, an additional dose of 5 mg can be administered to total no more than 10 mg.5
    • Patients who respond generally show dramatic improvement in muscle strength, regaining facial expression, posture, and respiratory function within 1 minute.
    • During this procedure, the patient must be monitored carefully because edrophonium can cause significant bradycardia, heart block, and asystole. The risk of serious bradyarrhythmias and syncope was only 0.16%, but atropine still should be available at the bedside.5 The return of muscle weakness after edrophonium wears off combined with residual increased oral secretions can exacerbate respiratory distress and the risk of aspiration.
    • Patients with a cholinergic crisis may respond to edrophonium challenge by increasing salivation and bronchopulmonary secretions, diaphoresis, and gastric motility (ie, SLUDGE syndrome).6,7 These changes should be managed expectantly, as the half-life of edrophonium is short (ie, approximately 10 min).
    • If muscle strength fails to improve following the maximum dose of edrophonium, the patient is having a cholinergic crisis or has another cause of weakness that is unrelated to myasthenia gravis.
    • The effects of edrophonium are brief, and repeated doses may be required before oral anticholinesterase medication can take effect.6
    • In patients with less severe exacerbations, the degree of improvement with edrophonium may be subtle. Many authors recommend having several blinded observers assess the patient's response in these cases. Some authors also suggest that a clear endpoint, such as improvement in eyelid ptosis or extraocular movements, since these muscles are independent of voluntary effort.5
  • Ice pack test
    • Cooling may improve neuromuscular transmission. In a patient with myasthenia gravis who has ptosis, placing ice over an eyelid will lead to cooling of the lid, which leads to improvement of the ptosis.
    • Lightly placing ice that is in a surgical glove or that is wrapped in a towel over the eyelid will cool it within 2 minutes.
    • A positive test is clear resolution of the ptosis.5
    • This test has a pooled sensitivity and specificity of 82% and 96%, respectively. However, the literature generally overestimates the usefulness since most of the studies were case-control designs.8
  • Additional tests (eg, standard electromyography, single-fiber electromyography, repetitive nerve stimulation, assays for acetylcholine receptor antibody [ARA]) are used to confirm the diagnosis of myasthenia gravis, but these tests usually are not available on an emergent basis.5 The ARA test offered the highest specificity of these additional tests since these other tests only reveal a disorder of neuromuscular conduction.8
  • Patients with respiratory distress should have an evaluation of pulmonary function, providing that the patient is not in obvious respiratory failure. 
    • This evaluation includes pulse oximetry, a measure of pulmonary function (ie, peak expiratory flow, forced expiratory volume in 1 second [FEV1]), and ABG sampling to determine PCO2 level.4
    • Evidence of hypoxemia, poor respiratory effort, or CO2 retention is an indication for intubation and mechanical ventilation.4

More on Myasthenia Gravis

Overview: Myasthenia Gravis
Differential Diagnoses & Workup: Myasthenia Gravis
Treatment & Medication: Myasthenia Gravis
Follow-up: Myasthenia Gravis
References

References

  1. Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve. Feb 2008;37(2):141-9. [Medline].

  2. Keesey JC. Clinical evaluation and management of myasthenia gravis. Muscle Nerve. Apr 2004;29(4):484-505. [Medline].

  3. [Best Evidence] Gajdos P, Chevret S, Toyka K. Intravenous immunoglobulin for myasthenia gravis. Cochrane Database Syst Rev. Jan 23 2008;CD002277. [Medline].

  4. Juel VC. Myasthenia gravis: management of myasthenic crisis and perioperative care. Semin Neurol. Mar 2004;24(1):75-81. [Medline].

  5. Meriggioli MN, Sanders DB. Advances in the diagnosis of neuromuscular junction disorders. Am J Phys Med Rehabil. Aug 2005;84(8):627-38. [Medline].

  6. Pascuzzi RM. Pearls and pitfalls in the diagnosis and management of neuromuscular junction disorders. Semin Neurol. Dec 2001;21(4):425-40. [Medline].

  7. Richman DP, Agius MA. Treatment of autoimmune myasthenia gravis. Neurology. Dec 23 2003;61(12):1652-61. [Medline].

  8. Benatar M. A systematic review of diagnostic studies in myasthenia gravis. Neuromuscul Disord. Jul 2006;16(7):459-67. [Medline].

  9. Mazia CG, De Vito EL, Varela M. BiPAP in acute respiratory failure due to myasthenic crisis may prevent intubation. Neurology. Jul 8 2003;61(1):144; author reply 144. [Medline].

  10. Seneviratne J, Mandrekar J, Wijdicks EF, Rabinstein AA. Noninvasive ventilation in myasthenic crisis. Arch Neurol. Jan 2008;65(1):54-8. [Medline].

  11. Saperstein DS, Barohn RJ. Management of myasthenia gravis. Semin Neurol. Mar 2004;24(1):41-8. [Medline].

  12. [Best Evidence] Schneider-Gold C, Gajdos P, Toyka KV, Hohlfeld RR. Corticosteroids for myasthenia gravis. Cochrane Database Syst Rev. Apr 18 2005;CD002828. [Medline].

  13. [Best Evidence] Hart IK, Sathasivam S, Sharshar T. Immunosuppressive agents for myasthenia gravis. Cochrane Database Syst Rev. Oct 17 2007;CD005224. [Medline].

  14. Dalakas MC. Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA. May 19 2004;291(19):2367-75. [Medline].

  15. [Best Evidence] Zinman L, Ng E, Bril V. IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial. Neurology. Mar 13 2007;68(11):837-41. [Medline].

  16. Rabinstein AA, Wijdicks EF. Warning signs of imminent respiratory failure in neurological patients. Semin Neurol. Mar 2003;23(1):97-104. [Medline].

  17. Pascuzzi RM. The edrophonium test. Semin Neurol. Mar 2003;23(1):83-8. [Medline].

  18. Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. Lancet. Jun 30 2001;357(9274):2122-8. [Medline].

  19. Evoli A, Batocchi AP, Tonali P. A practical guide to the recognition and management of myasthenia gravis. Drugs. Nov 1996;52(5):662-70. [Medline].

  20. Lacomis D. Myasthenic crisis. Neurocrit Care. 2005;3(3):189-94. [Medline].

Further Reading

Keywords

myasthenia gravis, myasthenic crisis, muscle weakness, autoimmune disorder of peripheral nerves, MG, acetylcholine nicotinic postsynaptic receptors, ACh, cholinergic nerve conduction, reduced muscle strength, autoantibodies, cholinergic crisis

Contributor Information and Disclosures

Author

William D Goldenberg, MD, Clinical Assistant Instructor, Department of Emergency Medicine, Kings County Hospital Center and SUNY Downstate Medical Center
William D Goldenberg, MD is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, Emergency Medicine Residents Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Richard H Sinert, DO, Associate Professor of Emergency Medicine, Clinical Assistant Professor of Medicine, Research Director, State University of New York College of Medicine; Consulting Staff, Department of Emergency Medicine, Kings County Hospital Center
Richard H Sinert, DO is a member of the following medical societies: American College of Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Medical Editor

Eric M Kardon, MD, FACEP, Attending Emergency Physician, Georgia Emergency Medicine Specialists; Physician, Division of Emergency Medicine, Athens Regional Medical Center
Eric M Kardon, MD, FACEP is a member of the following medical societies: American College of Emergency Physicians
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

J Stephen Huff, MD, Associate Professor, Emergency Medicine and Neurology, Department of Emergency Medicine, University of Virginia Health Sciences Center
J Stephen Huff, MD is a member of the following medical societies: American Academy of Emergency Medicine, American Academy of Neurology, American College of Emergency Physicians, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Rick Kulkarni, MD, Medical Director, Assistant Professor of Surgery, Section of Emergency Medicine, Yale-New Haven Hospital
Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: WebMD Salary Employment

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.